Jeffrey Graham
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
-
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 44
-
- Cancer Genomics and Diagnostics 14
- Co-authors
- Daniel Y.C. Heng (19 shared papers)Shaan Dudani (6 shared papers)Daniel Yick Chin Heng (6 shared papers)Toni K. Choueiri (16 shared papers)Aaron R. Hansen (22 shared papers)Ulka N. Vaishampayan (10 shared papers)Frede Donskov (18 shared papers)Georg A. Bjarnason (31 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Clinical Genitourinary Cancer (5 papers)European Urology (3 papers)Cancer Treatment Reviews (3 papers)European Urology Oncology (3 papers)
- Partner nations
- CanadaUnited StatesDenmark
In The Last Decade
Jeffrey Graham
51 papers receiving 601 citations
Peers
Comparison fields: 5 of 67
- Pulmonary and Respiratory Medicine 423
- Cancer Research 126
- Oncology 150
- Molecular Biology 171
- Neurology 27
Countries citing papers authored by Jeffrey Graham
This map shows the geographic impact of Jeffrey Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Graham more than expected).
Fields of papers citing papers by Jeffrey Graham
This network shows the impact of papers produced by Jeffrey Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Graham. The network helps show where Jeffrey Graham may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Graham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 66 | |
| 2 | 2018 | 53 | |
| 3 | 2020 | 43 | |
| 4 | 2017 | 34 | |
| 5 | 2019 | 31 | |
| 6 | 2019 | 30 | |
| 7 | Effect of ritanserin, a highly selective 5-HT2 receptor antagonist, on Parkinson's disease. | 1992 | 30 |
| 8 | 2019 | 26 | |
| 9 | 2018 | 26 | |
| 10 | 2019 | 22 | |
| 11 | 2022 | 21 | |
| 12 | 2022 | 20 | |
| 13 | 2016 | 17 | |
| 14 | 2018 | 16 | |
| 15 | 2020 | 13 | |
| 16 | 2015 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2018 | 11 | |
| 19 | 2018 | 11 | |
| 20 | 2020 | 11 |
About Jeffrey Graham
Jeffrey Graham is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Oncology and Economics and Econometrics, having authored 57 papers that have together received 608 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (44 papers), Cancer Genomics and Diagnostics (14 papers), Renal and related cancers (11 papers), Cancer Immunotherapy and Biomarkers (6 papers), Economic and Financial Impacts of Cancer (6 papers), Bladder and Urothelial Cancer Treatments (3 papers), Neurological disorders and treatments (2 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (423 citations), Cancer Research (126 citations), Oncology (150 citations), Molecular Biology (171 citations) and Neurology (27 citations). Jeffrey Graham has collaborated with scholars based in Canada, United States and Denmark. Frequent co-authors include Daniel Y.C. Heng, Shaan Dudani, Daniel Yick Chin Heng, Toni K. Choueiri, Aaron R. Hansen, Ulka N. Vaishampayan, Frede Donskov, Georg A. Bjarnason, J. Connor Wells and Lori Wood. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, European Urology, Cancer Treatment Reviews and European Urology Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.